(Q33395054)

26 July 2017

1 reference

title

Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures (English)

1 reference

26 July 2017

1 reference

Ahmad Beydoun

1

1 reference

26 July 2017

Joseph D'Souza

series ordinal

2

1 reference

26 July 2017

David Hebert

series ordinal

3

1 reference

26 July 2017

Pamela Doty

series ordinal

4

1 reference

26 July 2017

1 January 2009

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

26 July 2017

1 reference

26 July 2017

9

1 reference

26 July 2017

1

1 reference

26 July 2017

33-42

1 reference

Effectiveness of first antiepileptic drug.

26 July 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Lacosamide: a review of preclinical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Seeking a mechanism of action for the novel anticonvulsant lacosamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Signaling networks in neuronal polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

The role of synaptic reorganization in mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.9.1.33

21 January 2018

Identifiers

DOI

10.1586/14737175.9.1.33

1 reference

26 July 2017

1 reference